| Literature DB >> 32164581 |
Jozefien Buyze1, Anja De Weggheleire2, Johan van Griensven2, Lutgarde Lynen2.
Abstract
BACKGROUND: Hepatitis C virus (HCV) infection is a major global health problem. WHO guidelines recommend screening all people living with HIV for hepatitis C. Considering the limited resources for health in low and middle income countries, targeted HCV screening is potentially a more feasible screening strategy for many HIV cohorts. Hence there is an interest in developing clinician-friendly tools for selecting subgroups of HIV patients for whom HCV testing should be prioritized. Several statistical methods have been developed to predict a binary outcome. Multiple studies have compared the performance of different predictive models, but results were inconsistent.Entities:
Keywords: CART; HCV-HIV co-infection; Logistic regression; Spiegelhalter-Knill-Jones
Mesh:
Year: 2020 PMID: 32164581 PMCID: PMC7069185 DOI: 10.1186/s12879-020-4909-z
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Patient characteristics
| Characteristics | Missing values | |
|---|---|---|
| Male, | 0 | 1307 (42.9) |
| Age, years, median (IQR) | 0 | 42.5 (36.3–48.1) |
| Poor CD4 recovery on ART, | 13 | 117 (4.0) |
| ALT, IU/L, median (IQR) | 0 | 28 (20–43) |
| AST, IU/L, median (IQR) | 0 | 26 (21–36) |
| Platelets, ×109 cells/L, median (IQR) | 0 | 266 (221–312) |
| APRI, median (IQR) | 0 | 0.29 (0.21–0.41) |
| Fatigue, myalgia/arthralgia, or anorexia/weight loss, | 0 | 301 (9.9) |
| Generalized pruritus, | 0 | 120 (3.9) |
| Diabetes mellitus, | 6 | 113 (3.7) |
| Partner or household member with liver disease, | 10 | 185 (6.1) |
Logistic regression
| Predictor | Adjusted OR | p-value |
|---|---|---|
| Age (per 10 years) | 1.66 | <0.001 |
| Male gender | 0.55 | 0.008 |
| Platelets (per 10×109 cells/L) | 0.91 | <0.001 |
| AST (per 10 IU/L) | 0.93 | 0.078 |
| ALT (per 10 IU/L) | 1.09 | 0.037 |
| APRI | 1.30 | 0.029 |
| Diabetes mellitus | ||
| Yes | 2.15 | 0.052 |
| Missing | 22.89 | 0.002 |
| Fatigue or myalgia/arthralgia | 1.35 | 0.33 |
| or anorexia/weight loss | ||
| Generalized pruritus | 1.83 | 0.16 |
| Household member and/or | ||
| partner with liver disease | ||
| Yes | 3.68 | <0.001 |
| Missing | 1.08 | 0.96 |
| Poor CD4 recovery on ART | ||
| Yes | 0.99 | 0.99 |
| Missing | 1.90 | 0.69 |
Prediction score
| score | no HCV co-infection | HCV co-infection | Total |
|---|---|---|---|
| logistic regression | |||
| -6 | 1 | 0 | 1 |
| -5 | 3 | 0 | 3 |
| -4 | 6 | 0 | 6 |
| -3 | 44 | 0 | 44 |
| -2 | 302 | 4 | 306 |
| -1 | 1116 | 8 | 1124 |
| 0 | 1022 | 33 | 1055 |
| 1 | 363 | 30 | 393 |
| 2 | 63 | 14 | 77 |
| 3 | 13 | 5 | 18 |
| 4 | 6 | 9 | 15 |
| 5 | 0 | 2 | 2 |
| 8 | 0 | 1 | 1 |
| Spiegelhalter-Knill-Jones | |||
| -2 | 1167 | 7 | 1174 |
| -1 | 936 | 9 | 945 |
| 0 | 245 | 11 | 256 |
| 1 | 329 | 16 | 345 |
| 2 | 194 | 28 | 222 |
| 3 | 61 | 24 | 85 |
| 4 | 6 | 8 | 14 |
| 5 | 1 | 3 | 4 |
Fig. 1CART. The leaves show the predicted HCV co-infection status, the probability of HCV co-infection and the percentage of observations in the leaf
Spiegelhalter-Knill-Jones
| Predictor | Unadjusted LR | Adjusted LR | score | ||
|---|---|---|---|---|---|
| LR+ | LR- | aLR+ | aLR- | ||
| Age ≥50 years | 2.25 | 0.71 | 2.18 | 0.72 | +1 |
| Male gender | 0.99 | 1.01 | - | - | |
| Platelets <200×109 cells/L | 3.46 | 0.62 | 1.69 | 0.82 | +1 |
| AST ≥30 IU/L | 2.21 | 0.28 | 1.48 | 0.53 | −1 |
| ALT ≥40 IU/L | 2.33 | 0.49 | - | - | |
| APRI ≥0.45 | 3.88 | 0.33 | 2.42 | 0.48 | +1/−1 |
| Diabetes mellitus | 3.76 | 0.90 | 2.14 | 0.94 | +1 |
| Fatigue or myalgia/arthralgia | 2.11 | 0.88 | - | - | |
| or anorexia/weight loss | |||||
| Generalized pruritus | 2.61 | 0.94 | 2.04 | 0.95 | +1 |
| Household member and/or | 3.21 | 0.87 | 3.62 | 0.85 | +1 |
| partner with liver disease | |||||
| Poor CD4 recovery on ART | 1.34 | 0.99 | - | - | |
Comparison of predictive performance
| Logistic regression | CART | Spiegelhalter-Knill-Jones | |
|---|---|---|---|
| log-likelihood | -201.3 | -267.8 | -209.6 |
| Area under ROC curve | 74.6% | 73.4% | 81.9% |
| Porportion of HCV | 7.8% | 28.8% | 12.1% |
| co-infections missed | |||
| Sensitivity | 92.2% | 71.2% | 87.9% |
| Specificity | 22.1% | 73.3% | 50.5% |
| Positive predictive value | 4.1% | 8.7% | 5.9% |
| Negative predictive value | 98.7% | 98.6% | 99.2% |
| Proportion for whom | 98.2% | 31.0% | 30.4% |
| HCV testing is needed |